Phosphocreatine (CAS 67-07-2): The Muscle Cell's Emergency Power Reserve

Phosphocreatine

Get One-Stop Solution from This Page

 Every competitive cyclist who has ever blown up on a steep climb understands intuitively what phosphocreatine does inside muscle cells, even if they have never heard the term. That moment when the legs suddenly stop responding — when the burning sensation gives way to pure mechanical failure — corresponds almost exactly to the depletion of phosphocreatine stores in the working muscle. Recovery starts only after those stores begin to replenish, and the speed of that replenishment determines how quickly an athlete can mount another hard effort. This is not sports science abstraction. It is a biochemical process that has made phosphocreatine one of the most carefully studied energy metabolites in exercise physiology and one of the most consequential raw materials in the nutraceutical manufacturing industry.

The Chemistry Behind the Energy Currency

  Phosphocreatine, also known as creatine phosphate or phosphorylcreatine, carries a high-energy phosphate group bonded to the guanidinium nitrogen of creatine. The compound’s molecular formula is C4H10N3O5P, and its molecular weight is 211.11 g/mol. The phosphate bond here is thermodynamically similar in energy content to the terminal phosphate bond in ATP. This structural feature is not incidental — it is the entire basis of the molecule’s physiological function. When ATP concentrations begin to fall during rapid, high-intensity work, the enzyme creatine kinase cleaves the phosphate group from phosphocreatine and transfers it to ADP, regenerating ATP in milliseconds without requiring oxygen. This reaction is so fast and so specific that it essentially defines what biochemists call the phosphagen energy system, which powers explosive movements lasting less than ten seconds.
 
What makes phosphocreatine particularly interesting from a manufacturing standpoint is that its sodium salt form — sometimes labeled phosphocreatine disodium or creatine phosphate sodium — shows improved solubility compared to the free acid form. Injectable pharmaceutical formulations intended for cardiac protection protocols during open-heart surgery use the disodium salt specifically because it dissolves completely in aqueous media without pH adjustment complications. This is a separate and more demanding market than the dietary supplement sector, and it drives very different quality requirements from suppliers.

Cardiac Protection: An Overlooked but Critical Application

  While the sports nutrition angle dominates popular discussion of creatine chemistry, cardiac surgeons working with cardioplegic solutions have been using phosphocreatine as a myocardial protective agent since research in the 1980s demonstrated that adding it to cardioplegia reduced ischemia-reperfusion injury during procedures requiring the heart to be stopped. The logic mirrors the muscle physiology: heart tissue depleted of ATP during ischemia recovers faster when phosphocreatine is available to rapidly resynthesize energy currency at reperfusion. Clinical centers in Europe and Asia have incorporated phosphocreatine-containing cardioplegic protocols with varying degrees of enthusiasm, but the pharmaceutical-grade demand this creates is real and requires documentation standards that typical food-grade creatine products do not meet.
 
For manufacturers supplying into this pharmaceutical segment, the specification demands differ substantially from sports nutrition. The acceptable heavy metal profile must be tighter. Residual solvent analysis matters more. Microbial contamination limits are stricter. And the testing methods must be formally validated rather than just operationally verified. Any supplier claiming to serve both market segments with the same production batch is either producing to the higher pharmaceutical standard across the board — which increases cost — or cutting corners on the pharmaceutical supply, which is an unacceptable risk.

Quality Considerations That Actually Matter in Procurement

  Phosphocreatine is not a particularly difficult molecule to characterize analytically, but several specification points cause real problems in procurement when buyers fail to ask the right questions upfront. The first is moisture content. Phosphocreatine is hygroscopic, and its water absorption behavior means that weight-based purity calculations must account for the moisture correction factor. Buyers who specify anhydrous purity without clarifying the analytical basis for that number will sometimes receive product that appears to meet specification but delivers less active material than expected because moisture was not properly accounted for in the calculation.
 
  The second issue is the counterion when purchasing salt forms. Phosphocreatine disodium and phosphocreatine free acid are not interchangeable in formulation without adjustment. Some suppliers ship whichever form they have in inventory if the buyer’s purchase order does not explicitly specify. This causes downstream formulation problems that are frustrating to diagnose because the active content per gram can appear acceptable while the ionic environment of the final product shifts from what was validated.
 
  The third consideration is phosphate group stability during storage. Phosphocreatine degrades via hydrolysis back to creatine and inorganic phosphate. The rate of this hydrolysis is highly sensitive to moisture exposure, temperature, and pH. Properly dried, packaged under inert atmosphere, and stored below 15°C, phosphocreatine maintains specification for 24 months. Warehoused under ambient tropical conditions without moisture control, degradation can become analytically measurable within six months. The shelf life stated on a CoA is only meaningful if the buyer knows the storage conditions under which that claim was validated.
Phosphocreatine

Industrial Supply from Shandong Lookchemical

  Shandong Lookchemical Co, Ltd. supplies phosphocreatine (CAS 67-07-2) to nutraceutical formulators, research institutions, and pharmaceutical compounders working across both the sports nutrition and cardiac protection market segments. Production is carried out under controlled humidity conditions, and each lot is tested for purity, moisture content, heavy metals, and microbial burden before release. Documentation packages include CoA, SDS, REACH registration confirmation for EU buyers, and TSCA notification status for US import requirements.
 
For pharmaceutical-grade inquiries involving injectable formulation or compounding applications, technical consultation with our chemistry team is available to discuss the specific analytical requirements that apply to your regulatory context.
 
 

Related News Recommendations

Our Factory Equipment